The effect of hypolipidemic drugs on plasma lipoproteins.
D010131:Aminosalicylic Acid / Q000494:pharmacology; D000818:Animals; D002792:Cholestyramine Resin / Q000494:pharmacology; D002994:Clofibrate / Q000494:pharmacology; D003084:Colestipol / Q000494:pharmacology; D003918:Dextrothyroxine / Q000494:pharmacology; D004285:Dogs; D004359:Drug Therapy, Combination; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008074:Lipoproteins / Q000096:biosynthesis / Q000097:blood*; D009355:Neomycin / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology; D051381:Rats; D012855:Sitosterols / Q000494:pharmacology
D000960:Hypolipidemic Agents; D008074:Lipoproteins; D009539:Nicotinic Acids; D012855:Sitosterols; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D010131:Aminosalicylic Acid; D002994:Clofibrate; D009355:Neomycin; D003084:Colestipol